Other

Knoll A.g. Chemische Fabriken

Hans Peter Albrecht

Bruce D Roth

Catherine R Kostlan

Hamish John Allen

Nigel P Walker

Kenneth Dale Brady

William Glen Harter

Guenter Neugebauer

Heinz E Moessner

Gunter Neugebauer

The present invention relates to compounds that are inhibitors of interleukin-1&bgr; converting enzyme that have the Formula (I). This invention also relates to a method of treatment of stroke, reperfusion injury, Alzheimer's disease, shigellosis, inflammatory diseases, and septic shock and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1&bgr; converting enzyme.

Sulfonamide interleukin-1&bgr; converting enzyme inhibitors

A roller blind unit in which the blind may be uncoiled from a spiral coil, the blind being made up of articulated slats and being trained along a generally level structure so that it is not acted upon by gravity to a high enough degree for operation without a power drive, has at least one flexible web-like driver element coiled up interleaved with the blind in the coil and trained at least partly around the outside of the blind coil. One end of the driver element is fixed to the take-up shaft on which the blind is coiled and the other end is anchored on a driving shaft.

Roller blind unit

Cardioactive glycosides of the formula ##STR1## are disclosed, wherein R.sub.1 is saturated aliphatic hydrocarbon having 1 - 4 carbon atoms or unsaturated aliphatic hydrocarbon having 2 - 4 carbon atoms or phenyl and R.sub.2 is hydrogen or hydroxyl, as are methods for making the same by reacting the corresponding aglycone with an acylated 1-halo-hexopyranose of the formula ##STR2## wherein Hal is halogen, R.sub.3 is hydrogen or alkanoyloxy having 1 - 4 carbon atoms, and R.sub.4 is alkanoyl having 1 - 4 carbon atoms or benzoyl, and subsequently cleaving the acyl groups.

Cardenolide glycosides and method of making the same, and therapeutic

Novel cardenolides having desirable cardiac activity and which are readily reabsorbed internally, a process for their preparation and therapeutic compositions containing said cardenolides are disclosed.

Cardenolides

Growing community of inventors

Munich, Georgia

Hans Peter Albrecht